These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36694298)

  • 1. Late airway complications following pediatric liver transplantation: A case series.
    Rajasekaran V; McCaffer C; Bishop J; Van Der Meer G; Toll EC; Evans H
    Pediatr Transplant; 2023 May; 27(3):e14473. PubMed ID: 36694298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-transplant lymphoproliferative disorder of the pediatric airway: Presentation and management.
    O'Neill AF; Adil EA; Irace AL; Neff L; Davis IJ; Perez-Atayde AR; Voss SD; Weinberg O; Rahbar R
    Int J Pediatr Otorhinolaryngol; 2016 Jul; 86():218-23. PubMed ID: 27260610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Various initial presentations of Epstein-Barr virus infection-associated post-transplant lymphoproliferative disorder in pediatric liver transplantation recipients: Case series and literature review.
    Simakachorn L; Tanpowpong P; Lertudomphonwanit C; Anurathapan U; Pakakasama S; Hongeng S; Treepongkaruna S; Phuapradit P
    Pediatr Transplant; 2019 Mar; 23(2):e13357. PubMed ID: 30661283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Airway inflammation and symptoms in children following liver and heart transplantation.
    Redmann AJ; Bucuvalas JC; Wood RE; Chin C; Hart CK
    Clin Transplant; 2017 Jun; 31(6):. PubMed ID: 28316109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience.
    Pinho-Apezzato ML; Tannuri U; Tannuri AC; Mello ES; Lima F; Gibelli NE; Santos MM; Ayoub AA; Maksoud-Filho JG; Velhote MC; Silva MM; Andrade WC; Miyatani HT
    Transplant Proc; 2010 Jun; 42(5):1763-8. PubMed ID: 20620519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-transplantation lymphoproliferative disease in pediatric liver recipients in Taiwan.
    Hsu CT; Chang MH; Ho MC; Chang HH; Lu MY; Jou ST; Ni YH; Chen HL; Hsu HY; Wu JF
    J Formos Med Assoc; 2019 Nov; 118(11):1537-1545. PubMed ID: 30630698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Early diagnosis and comprehensive treatments of post-transplantation lymphoproliferative disorder after pediatric liver transplantation].
    Deng Z; Jiang L; Zhou T; Shen C; Chen Q; Xia Q
    Zhonghua Er Ke Za Zhi; 2014 Aug; 52(8):579-82. PubMed ID: 25224233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus DNA monitoring in serum and whole blood in pediatric liver transplant recipients who do or do not discontinue immunosuppressive therapy.
    Kullberg-Lindh C; Saalman R; Olausson M; Herlenius G; Lindh M
    Pediatr Transplant; 2017 Aug; 21(5):. PubMed ID: 28039929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case report: an unusal cause of stridor in a post-liver transplant 6-year old.
    Rafferty MA; Devaney D; Russell J
    Int J Pediatr Otorhinolaryngol; 2000 Aug; 54(2-3):149-51. PubMed ID: 10967386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M; Desai DM; Cox KL; Berquist WE; Esquivel CO; Millan MT
    Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent posttransplant lymphoproliferative disorder involving the larynx and trachea: case report and review of the literature.
    Banks CA; Meier JD; Stallworth CR; White DR
    Ann Otol Rhinol Laryngol; 2012 May; 121(5):291-5. PubMed ID: 22724273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-associated risk factors for post-transplant lymphoproliferative disease in pediatric liver transplant recipients.
    Quintero Bernabeu J; Juamperez J; Mercadal-Hally M; Larrarte King M; Gallego Melcon S; Gros Subias L; Sábado Álvarez C; Soler-Palacin P; Melendo Pérez S; Esperalba J; Navarro Jiménez A; Garrido Pontnou M; Camacho Soriano J; Hidalgo Llompart E; Bilbao Aguirre I; Charco Torra R
    Pediatr Transplant; 2022 Sep; 26(6):e14292. PubMed ID: 35466492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttransplant lymphoproliferative disorder presenting in the head and neck.
    Lattyak BV; Rosenthal P; Mudge C; Roberts JP; Renze JF; Osorio RW; Emond JC; Lalwani AK
    Laryngoscope; 1998 Aug; 108(8 Pt 1):1195-8. PubMed ID: 9707243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreasing incidence of symptomatic Epstein-Barr virus disease and posttransplant lymphoproliferative disorder in pediatric liver transplant recipients: report of the studies of pediatric liver transplantation experience.
    Narkewicz MR; Green M; Dunn S; Millis M; McDiarmid S; Mazariegos G; Anand R; Yin W;
    Liver Transpl; 2013 Jul; 19(7):730-40. PubMed ID: 23696264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction regimens and post-transplantation lymphoproliferative disorder after pediatric intestinal transplantation: Single-center experience.
    Devine K; Ranganathan S; Mazariegos G; Bond G; Soltys K; Ganoza A; Sun Q; Sindhi R
    Pediatr Transplant; 2020 Aug; 24(5):e13723. PubMed ID: 32424963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous involvement of polymorphic post-transplant lymphoproliferative disorder in a child after liver transplantation.
    Chen KY; Lin CY; Kuo TT; Shih LY; Chang CH; Chen WT; Yang CY
    Pediatr Dermatol; 2019 Sep; 36(5):681-685. PubMed ID: 31215060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-transplantation lymphoproliferative disorder in living-donor liver transplantation: a single-center experience.
    Nakanishi C; Kawagishi N; Sekiguchi S; Akamatsu Y; Sato K; Miyagi S; Takeda I; Fukushima D; Kobayashi Y; Ishida K; Niizuma H; Tsuchiya S; Wada M; Nio M; Satomi S
    Surg Today; 2012 Aug; 42(8):741-51. PubMed ID: 22278621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression.
    Newell KA; Alonso EM; Whitington PF; Bruce DS; Millis JM; Piper JB; Woodle ES; Kelly SM; Koeppen H; Hart J; Rubin CM; Thistlethwaite JR
    Transplantation; 1996 Aug; 62(3):370-5. PubMed ID: 8779685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients.
    McDiarmid SV; Jordan S; Kim GS; Toyoda M; Goss JA; Vargas JH; Martín MG; Bahar R; Maxfield AL; Ament ME; Busuttil RW
    Transplantation; 1998 Dec; 66(12):1604-11. PubMed ID: 9884246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience.
    Kogan-Liberman D; Burroughs M; Emre S; Moscona A; Shneider BL
    J Pediatr Gastroenterol Nutr; 2001 Oct; 33(4):445-9. PubMed ID: 11698761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.